Prevalence of opportunistic infections in Syrian inflammatory bowel disease patients on biologic therapy: a multi-center retrospective cross-sectional study

Abstract Background Hepatitis B, hepatitis C, cytomegalovirus (CMV), and tuberculosis (TB) pose significant risks to patients with inflammatory bowel disease (IBD) receiving biological therapy. However, data on the prevalence of these infections in Syria are scarce. Methods We conducted a retrospect...

Descripció completa

Dades bibliogràfiques

Autors principals:	Marouf Alhalabi, Hussam Aldeen Alshiekh, Shadi Alsaiad, Mouayad Zarzar
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2025-05-01
Col·lecció:	BMC Infectious Diseases
Matèries:	Ulcerative colitis Crohn's disease Inflammatory bowel disease Hepatitis B Hepatitis C Tuberculosis
Accés en línia:	https://doi.org/10.1186/s12879-025-11063-6
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!